区域化远程卒中医疗在基层医院急性缺血性卒中患者静脉溶栓诊疗中的应用分析
|
摘要
目的探讨区域化远程卒中医疗在基层医院急性缺血性卒中(AIS)患者静脉溶栓诊疗中的应用价值。方法将2016年1―12月建立区域化远程卒中医疗前的AIS患者436例作为对照组;将2017年1―12月建立区域化远程卒中医疗后的AIS患者608例作为试验组。对两组的静脉溶栓率和入院到静脉溶栓时间(DNT)进行分析,比较区域化远程卒中医疗建立前后,AIS患者静脉溶栓率及DNT变化情况。结果开展区域化远程卒中医疗后,就诊的AIS患者静脉溶栓率(3.29%)较前(0.92%)明显增加(<0.05),DNT明显缩短(<0.05)。结论区域化远程卒中医疗可提高基层医院AIS患者的静脉溶栓率,并可缩短DNT,是缩短基层医院AIS患者救治时间的一种全新有效的医疗模式。
引文
[1]Levine SR,Gorman M."Telestroke":the application of telemedicine for stroke[J].Stroke,1999,30(2):464-469.
[2]Del ZG,Saver JL,Jauch EC,et al.Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator:a science advisory from the American Heart Association/American Stroke Association[J].Stroke,2009,40(8):2945-2948.
[3]Lees KR,Bluhmki E,von Kummer R,et al.Time to treatment with intravenous alteplase and outcome in stroke:an updated pooled analysis of ECASS,ATLANTIS,NINDS,and EPITHET trials[J].Lancet,2010,375(9727):1695-1703.
[4]中华医学会神经病学分会.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246-257.
[5]重组组织型纤溶酶原激活剂治疗缺血性卒中共识专家组.重组组织型纤溶酶原激活剂静脉溶栓治疗缺血性卒中中国专家共识(2012版)[J].中华内科杂志,2012,51(12):1006-1010.
[6]Liu L,Wang D,Wong KS,et al.Stroke and stroke care in China:Huge burden,significant workload,and a national priority[J].Stroke,2011,42:3651-3654.
[7]La Monte MP,Cullen J,Gagliano DM,et al.TeleBAT:mobile telemedicine for the Brain Attack Team[J].J Stroke Cerebrovasc Dis,2000,9(3):128-135.
[8]Demaerschalk BM,Vegunta S,Vargas BB,et al.Reliability of real-time video smartphone for assessing National Institutes of Health Stroke Scale scores in acute stroke patients[J].Stroke,2012,43(12):3271-3277.
[2]Del ZG,Saver JL,Jauch EC,et al.Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator:a science advisory from the American Heart Association/American Stroke Association[J].Stroke,2009,40(8):2945-2948.
[3]Lees KR,Bluhmki E,von Kummer R,et al.Time to treatment with intravenous alteplase and outcome in stroke:an updated pooled analysis of ECASS,ATLANTIS,NINDS,and EPITHET trials[J].Lancet,2010,375(9727):1695-1703.
[4]中华医学会神经病学分会.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246-257.
[5]重组组织型纤溶酶原激活剂治疗缺血性卒中共识专家组.重组组织型纤溶酶原激活剂静脉溶栓治疗缺血性卒中中国专家共识(2012版)[J].中华内科杂志,2012,51(12):1006-1010.
[6]Liu L,Wang D,Wong KS,et al.Stroke and stroke care in China:Huge burden,significant workload,and a national priority[J].Stroke,2011,42:3651-3654.
[7]La Monte MP,Cullen J,Gagliano DM,et al.TeleBAT:mobile telemedicine for the Brain Attack Team[J].J Stroke Cerebrovasc Dis,2000,9(3):128-135.
[8]Demaerschalk BM,Vegunta S,Vargas BB,et al.Reliability of real-time video smartphone for assessing National Institutes of Health Stroke Scale scores in acute stroke patients[J].Stroke,2012,43(12):3271-3277.